walvax biotechnology co-a
(300142:Shenzhen Stock Exchange)
Transactions by WALVAX BIOTECHNOLOGY CO-A (300142) in the last 6 months
Shenzhen Derun Tianqing Investment Management Partnership (Limited Partnership) entered into agreement to acquire 15% stake in Shandong Shijie Biological Pharmaceutical Co, Ltd. from Walvax Biotechnology Co.,Ltd (SZSE:300142) for CNY 180 million on June 10, 2015. On closing, Walvax will hold 85% stake in Shandong Shijie Biological Pharmaceutical Co, Ltd. Board of Directors of Walvax Biotechnology Co.,Ltd approved the transaction.
Walvax Biotechnology Co.,Ltd (SZSE:300142), Hangzhou Tigermed Consulting Co., Ltd. (SZSE:300347), Sinkiang-based equity investment company and other investors signed an equity acquisition agreement to acquire a 54% stake in Taizhou Jietong Tairui Pharmaceutical Technology Co., Ltd. from Xinjiang Tairui Equity Investment Partnership, Fu Xiaoyang and another individual on April 8, 2015. The acquisition will be made through a newly established fund with a registration capital ...
Walvax Biotechnology Co.,Ltd
Walvax Biotechnology Co.,Ltd (SZSE:300142) agreed to acquire an additional 8.83% stake in Genor BioPharma Co., Ltd. from Wison (China) Investment Co., Ltd. for CNY 85 million on March 19, 2015. An equity transfer agreement with Wison (China) Investment Co., Ltd. will be signed. Genor Biopharma had total assets of CNY 105.74 million, total liabilities of CNY 116.22 million, net liabilities of CNY 10.48 million, revenue of CNY 0.39 million and net loss of CNY 63.58 million ...
|No competitor information is available for 300142.|
|View Industry Companies|